R&D Europe91235418
08:00 AM CEST

Medicinal Chemistry

Strategy Meeting Europe 2023

Reinvigorating Productivity in Pharma & Biotech R&D Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms

What makes our strategy meetings unique?


Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.


Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.


Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.


Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.


Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.


Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Past Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our 2022 Medicinal Chemistry strategy meeting.

Lurong Pan

Founder and CEO Ainnocence

Asif Ahmed

Executive Chairman and CEO MIRZYME

Daniel Gironés

Senior Vice President Drug Discovery Protinhi Therapeutics

Edgar Jacoby

Senior Principal Scientist Computational Chemistry The Janssen Pharmaceutical Companies of Johnson & Johnson

Henrik Keränen

Research Scientist and Head of Computational Chemistry Section Lundbeck

Guido Koch

Chief Executive Officer Amphilix AG

Philippe Pinton

Vice-President, Global Head of Translational Medicine and Clinical Pharmacology Ferring Pharmaceuticals

Stefan Schiesser

Associate Principal Scientist AstraZeneca
See the complete agenda and facilitator line-up Download the strategy meeting brochure for full details

Who Should Attend the Event?

Chief Executive Officers

Executive Vice Presidents

Vice Presidents

Executive Directors


Global Heads

Responsible For:

Medicinal Chemist

Computational Chemist



In-Silico/In-vivo/In-vitro Chemist/Biologist

Chemical Biology

Molecular Chemist/Biologist

Hit and Lead Chemist

Small/Large Molecules Chemist

Drug Discovery or Drug Development

See Which Topics Are Discussed at the Strategy Meeting

Reasons To Attend the Strategy Meeting

Demonstrating effective implementation of new technologies such as AI/ML in drug discovery

Delving into the intersection between chemical biology and drug discovery

Exploring leaps in optimizing novel therapeutic modalities

Augmenting draggability with new modalities

image_one image_two image_three

Press play to hear what your colleagues had to say…

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.

    I agree to Proventa International storing this information to reply to my query and in accordance with our Privacy Policy.
    You may unsubscribe at any time.

    Quick Links

    Want to find out more?

    Find out more details about our Strategy Meetings and other news and events.